Chinese Journal of Clinical Hepatology 2011 Issue 4 Current state and development tendency of tumor therapeutic antibody

Current state and development tendency of tumor therapeutic antibody
XU Zeng-hui;QIAN Qi-jun

..............page:351-356

Meta-analysis of 111 patients with nonalcoholic steatohepatitis-asseciated hepatocellular carcinoma
DUAN Xiao-yan;FAN Jian-gao

..............page:382-386

Advances on the polyeystic liver diseases
TIAN Hui

..............page:446-449

Surgical treatment of giant primary liver cancer
wu de quan ; gao feng ; sun dong sheng ; zeng zhao lin ; chou gong cai ; zhang xin chen

..............page:372-374,390

Relationship between adiponectin and β-cell function and insulin resistance in female patients with nonalcoholic fatty liver disease
cha ying ; liu jun ; sheng li ; chen zao ping ; yang ling zuo ; chen qin da ; liao xiao zuo ; meng ling ping

..............page:420-423

Analysis of the clinical symptom and its relationship with the clinical classification of hilar cholangiocarcinoma
zhang wei ; han xin wei ; wu gang ; li zhen ; ding peng xu

..............page:405-407

xin xi dong tai

..............page:371,377,402,445

Serum thymosin β4 level in patients with hepatocellular carcinoma
xing jing ; han tao ; zhu zheng yan ; liu ying ; liu hua ; guo zhen ; ma xiao yan ; pei yan zuo

..............page:387-390

A case report of autoimmune pancreatitis
ZHOU Su-min;GAO Pu-jun;GAO Run-ping

..............page:424,436

The clinical observation of sonographically guided percutaneous microwave coagulation of liver tumors abutting danger areas
liu jian yong ; lu wei ; zhou yong he ; cao hong bo ; zhou guo qiang ; cao zhi

..............page:375-377

Changes in serum level of interleukin-32 and interleukin-6 in patients with chronic hepatitis B virus infection and its clinical significance
ZUO Wei-ze;XU Chun-mei;SHEN Lan-chao

..............page:408-410,413

Treatment strategies for liver cancer
TANG Zhao-you

..............page:337-339

Optimal strategy for chronic hepatitis B patients receiving nucleos(t)ide analogue antiviral treatment

..............page:340-342

Associated expression of Plk1 and p21WAF1/CIP1 in hepatocellular carcinoma
li hui ; zhang zuo ; lu feng min ; xu chun zuo ; tang zuo ai ; chen xiang mei ; ma jun

..............page:394-396

Observation of long-term efficacy of different treatment protocol of Adefovir dipivoxil in chronic hepatitis B patients with Lamivudine-resistance
GU Qiang-ye;LI Qin;GE Xiu-lin

..............page:411-413

The diagnostic role of combination of glypican-3 and AFP in primary hepatic carcinoma
song meng zuo ; yang yong fei ; wang dong dong ; you fa ping ; chen li bo

..............page:391-393,399

Prognostic accuracy of staging systems in patients with primary liver cancer treated with transarterial chemoembolization
zhang feng ; zhu ge yu zheng ; chou zuo dong ; huang xin ; li zhen lei ; zhang jian wu

..............page:378-381

The role of radiofrequency ablation in multidisciplinary treatment of hepatocellular carcinoma
CHEN Min-shan;LIU Fu-rong

..............page:368-371

The role of immune cells in immune tolerance mechanisms towards chronic hepatitis B
LI Jun-qing

..............page:437-440

Clinical analysis of misdiagnosis and missed diagnosis of hepaterenal syndreme
chen sheng peng ; he wei ping ; li yu fang ; wu ji jun

..............page:444-445

Comparison of diagnostic and treatment algorithm of America, Asia-Pacific and China for hepatocellular carcinoma
FAN Jia;PAN Qi;SHI Ying-hong

..............page:346-347,364

Pathological and imaging features of multistep process of cirrhosis nodules
REN Song

..............page:425-428

Individual and comprehensive therapy for primary liver cancer
CAI Jian-qiang;BI Xin-yu

..............page:365-367

Experts consensus on pathological diagnosis of primary liver cancer

..............page:343-345

Expression of Plk1 and Survivin in hepatocellular carcinoma and its significance
LIU Qi-sheng;XU Xiao-hong;LIU Huai

..............page:397-399

Three dimensional conformation radiotherapy for 35 cases of unresectable massive primary liver cancer
han shou yun ; xia huo sheng ; zhang yu hai ; li ping ; liu zhi chen

..............page:403-404,407

Virological response of chronic hepatitis C treated with peg-interferon a-2a and Ribavirin
JIANG Xue-qiang;ZOU Xiao-jing;TIAN De-ying

..............page:417-419

Yttrium 90 microspheres in the management of hepatocellular carcinoma
LAU Wan Yee;LAI Eric C.H.;LAU Stephanie H. Y

..............page:348-350

Prediction of hepatocellular carcinoma risk in chronic hepatitis B and C: review of findings in REVEAL-HBV/HCV study
YANG Hwai-I;LEE Mei-Hsuan;CHEN Chien-Jen

..............page:357-362

Contribution of diffusion weighted MR imaging in the differential diagnosis of focal hepatic lesions at 3T
feng hai long ; li cai ying ; wang ying jie ; feng ping yong ; cui cai xia

..............page:400-402

Bio-degradable nanoparticles for sustained delivery of siRNAs targeting inhibition of hepatitis C virus replication in vitro
XIAO Fei;LIU Fan-ling;NING Qin

..............page:414-416,423

Promoter methylation in APC, RASSFIA, WIF-1 gene in digestive system tumors
ZHANG Hui-jing

..............page:429-432

Predicting scoring system for hepatocellular carcinoma development in chronic hepatitis B patients Vincent
Wai-Sun Wang;YANG Li

..............page:363-364

Research progress of angiopoietins in hepatocellular carcinoma
zhang hua min ; zhao zheng bin ; xiong ya xing ; chen hong

..............page:433-436

The role of leptin and adiponectin in non-alcoholic fatty liver disease
KONG Yin

..............page:441-443